Alnylam Pharmaceuticals (ALNY) Q3 2016 Earnings

4AugConfirmed
Q4 2015
Q1 2016
Q2 2016
Q3 2016
-1.25
-1.14
-1.02
-0.91

Details

Expected EPS
-1.25
Actual EPS
-1.05
Surprise EPS
0.2
Surprise Percent
+16%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of -1.05 per share for Q3 2016.

0 Comments

Share your thoughts